James Altucher:

The Night I Fell in Love With Google

I once woke up in the middle of the night, convinced I was in love, not with a person, but with Google. 

Back in 2007, I’d walked into their Manhattan office hoping they’d buy my startup, only to fall headfirst for a company that felt like its own alternate universe. 

The rejection that followed felt devastating, the kind of “end of the story” moment you replay for years. But what I didn’t understand then was how that heartbreak would quietly reroute the rest of my life. 

This is the story of how not being chosen by Google became the opening to everything that came after…

⇒ Read More Here

Ray Blanco:

Scientists Close In on a Universal Cancer Vaccine

A research team at the University of Massachusetts Amherst has shown that a nanoparticle-based vaccine can successfully prevent melanoma, pancreatic cancer, and triple-negative breast cancer in mice. 

Depending on the cancer type, as many as 88% of vaccinated mice remained free of tumors (depending on the cancer), and the approach reduced — and in some instances entirely blocked — the spread of cancer in the body.

By engineering these nanoparticles to activate the immune system via multi-pathway activation that combines with cancer-specific antigens, scientists say they can prevent tumor growth with remarkable survival rates.

⇒ Read More Here

Ian Culley:

Breakout Alert: Copper Coils for a Monster Move

Stocks that delivered the bulk of returns last quarter are now causing more headaches than anything else. And don’t even get me started on crypto… What a hot mess!

You can’t deny the market melt-up doubts growing in the pit of your stomach.

Yet despite persistent challenges for the broad U.S. stock market, not all stocks are stuck in a rut.

Some names are actually rising and offering investors a chance to capture a bit of that long-awaited seasonal strength.

⇒ Read More Here